54 related articles for article (PubMed ID: 28705617)
1. Influence of process and formulation parameters on the preparation of solid lipid nanoparticles by dual centrifugation.
Steiner D; Bunjes H
Int J Pharm X; 2021 Dec; 3():100085. PubMed ID: 34159313
[TBL] [Abstract][Full Text] [Related]
2. Solubility of Poorly Soluble Drugs in Phosphatidylcholine-Based Drug Delivery Systems: Comparison of the Loading Capacity in the Bulk Formulation and Its Dispersed State.
Grüne L; Bunjes H
Pharmaceuticals (Basel); 2024 Mar; 17(3):. PubMed ID: 38543186
[TBL] [Abstract][Full Text] [Related]
3. Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs.
Preeti ; Sambhakar S; Malik R; Bhatia S; Al Harrasi A; Rani C; Saharan R; Kumar S; Geeta ; Sehrawat R
Scientifica (Cairo); 2023; 2023():6640103. PubMed ID: 37928749
[TBL] [Abstract][Full Text] [Related]
4. Interactions between Quantum Dots and G-Actin.
Le N; Chand A; Braun E; Keyes C; Wu Q; Kim K
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834208
[TBL] [Abstract][Full Text] [Related]
5. Nanostructured Lipid Carriers Mediated Drug Delivery to Posterior Segment of Eye and their
Singh AK; Kumar M; Upadhyay PK
Curr Pharm Biotechnol; 2024; 25(6):713-723. PubMed ID: 37691214
[TBL] [Abstract][Full Text] [Related]
6. Current Advances in the Biomedical Applications of Quantum Dots: Promises and Challenges.
Le N; Kim K
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628860
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanoparticles as a Promising Drug Delivery Carrier for Topical Ocular Therapy-An Overview on Recent Advances.
Jacob S; Nair AB; Shah J; Gupta S; Boddu SHS; Sreeharsha N; Joseph A; Shinu P; Morsy MA
Pharmaceutics; 2022 Feb; 14(3):. PubMed ID: 35335909
[TBL] [Abstract][Full Text] [Related]
8. Development and Characterization of Stingless Bee Propolis Properties for the Development of Solid Lipid Nanoparticles for Loading Lipophilic Substances.
Khongkaew P; Chaemsawang W
Int J Biomater; 2021; 2021():6662867. PubMed ID: 34135970
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Cannabidiol in Colloidal Lipid Carriers.
Francke NM; Schneider F; Baumann K; Bunjes H
Molecules; 2021 Mar; 26(5):. PubMed ID: 33800445
[TBL] [Abstract][Full Text] [Related]
10. Influence of drug loading on the physical stability of phospholipid-stabilised colloidal lipid emulsions.
Francke NM; Bunjes H
Int J Pharm X; 2020 Dec; 2():100060. PubMed ID: 33305256
[TBL] [Abstract][Full Text] [Related]
11. Stabilized Production of Lipid Nanoparticles of Tunable Size in Taylor Flow Glass Devices with High-Surface-Quality 3D Microchannels.
Erfle P; Riewe J; Bunjes H; Dietzel A
Micromachines (Basel); 2019 Mar; 10(4):. PubMed ID: 30934803
[TBL] [Abstract][Full Text] [Related]
12. Nanosystems in Edible Coatings: A Novel Strategy for Food Preservation.
Zambrano-Zaragoza ML; González-Reza R; Mendoza-Muñoz N; Miranda-Linares V; Bernal-Couoh TF; Mendoza-Elvira S; Quintanar-Guerrero D
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494548
[TBL] [Abstract][Full Text] [Related]
13. Drug solubility in lipid nanocarriers: Influence of lipid matrix and available interfacial area.
Göke K; Bunjes H
Int J Pharm; 2017 Aug; 529(1-2):617-628. PubMed ID: 28705617
[TBL] [Abstract][Full Text] [Related]
14. Carrier characteristics influence the kinetics of passive drug loading into lipid nanoemulsions.
Göke K; Bunjes H
Eur J Pharm Biopharm; 2018 May; 126():132-139. PubMed ID: 28807819
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticles: drug localization is substance-specific and achievable load depends on the size and physical state of the particles.
Kupetz E; Bunjes H
J Control Release; 2014 Sep; 189():54-64. PubMed ID: 24933601
[TBL] [Abstract][Full Text] [Related]
16. Parameters influencing the course of passive drug loading into lipid nanoemulsions.
Göke K; Bunjes H
Eur J Pharm Biopharm; 2018 May; 126():123-131. PubMed ID: 28529070
[TBL] [Abstract][Full Text] [Related]
17. Nanonization techniques to overcome poor water-solubility with drugs.
Da Silva FLO; Marques MBF; Kato KC; Carneiro G
Expert Opin Drug Discov; 2020 Jul; 15(7):853-864. PubMed ID: 32290727
[TBL] [Abstract][Full Text] [Related]
18. Improvement of drug safety by the use of lipid-based nanocarriers.
Lim SB; Banerjee A; Önyüksel H
J Control Release; 2012 Oct; 163(1):34-45. PubMed ID: 22698939
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
